NCT01019616 2021-11-29Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary ChemotherapyPeking UniversityPhase 3 Unknown400 enrolled
NCT03270007 2020-10-28Research of Intensive Treatment in Hormone Receptor<10% and Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer Patients With Positive Lymph Node Residual Disease After Neoadjuvant ChemotherapyPeking UniversityPhase 4 Unknown304 enrolled